Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of 60 DEGREES PHARMACEUTICALS, INC. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
60 DEGREES PHARMACEUTICALS, INC. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • 60 DEGREES PHARMACEUTICALS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2025 was $4,346,958, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

60 DEGREES PHARMACEUTICALS, INC. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,346,958 -$1,615,889 -27% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,345,704 -$613,680 -21% 30 Jun 2025 10-Q 13 Nov 2025 2025 Q3
Q1 2025 $4,028,889 -$3,096,589 -43% 31 Mar 2025 10-Q 13 Nov 2025 2025 Q3
Q4 2024 $3,955,006 -$843,090 -18% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $5,962,847 -$553,403 -8.5% 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $2,959,384 +$27,672,325 30 Jun 2024 10-Q 13 Nov 2025 2025 Q3
Q1 2024 $7,125,478 +$28,494,454 31 Mar 2024 10-Q 13 Nov 2025 2025 Q3
Q4 2023 $4,798,096 +$28,947,156 31 Dec 2023 10-Q 13 Nov 2025 2025 Q3
Q3 2023 $6,516,250 +$29,014,379 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $24,712,941 -$3,671,896 -17% 30 Jun 2023 10-Q 14 Nov 2024 2024 Q3
Q1 2023 $21,368,976 -$2,403,601 -13% 31 Mar 2023 10-Q 14 Nov 2024 2024 Q3
Q4 2022 $24,149,060 -$5,994,576 -33% 31 Dec 2022 10-K 27 Mar 2025 2024 FY
Q3 2022 $22,498,129 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $21,041,045 30 Jun 2022 10-Q 20 Nov 2023 2023 Q3
Q1 2022 $18,965,375 31 Mar 2022 10-Q 20 Nov 2023 2023 Q3
Q4 2021 $18,154,484 31 Dec 2021 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.